Psykey, Inc. Logo

Psykey, Inc.

CEOS

(1.2)
Stock Price

0,03 USD

-273.19% ROA

671.52% ROE

-6.13x PER

Market Cap.

286.956,00 USD

-135.21% DER

0% Yield

-292.09% NPM

Psykey, Inc. Stock Analysis

Psykey, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Psykey, Inc. Fundamental Stock Analysis
# Analysis Rating
1 PBV

The stock's low PBV ratio (0.17x) suggests it's undervalued, making it an attractive opportunity for investors.

2 Revenue Growth

Company's revenue has experienced consistent growth over the last three years, indicating a favorable financial trajectory and making it an attractive investment choice.

3 Net Profit Growth

This company's net profit has been consistently on the rise over the past three years, indicating a strong financial performance and making it an appealing investment opportunity.

4 Graham Number

The company's Graham number indicates that it is undervalued compared to its stock price, suggesting a potentially favorable investment opportunity.

5 ROE

Negative ROE (-272.03%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

6 ROA

The stock's ROA (-411.9%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

7 DER

The company has a high debt to equity ratio (136%), which means it owes a lot of money compared to what it actually owns, making it financially risky.

8 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

9 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

10 Dividend

The company has not distributed any dividends in the past three years, which may raise concerns for investors looking for regular income from their investments.

11 Buffet Intrinsic Value

The company's stock appears overvalued (0) by Warren Buffett's formula, suggesting a less favorable investment opportunity as its market price exceeds its estimated intrinsic value.

Psykey, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Psykey, Inc. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Buy
2 MACD Sell
3 RSI Hold
4 Stoch RSI Hold

Psykey, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Psykey, Inc. Revenue
Year Revenue Growth
2005 0
2006 0 0%
2007 0 0%
2008 0 0%
2014 7.360.012 100%
2015 3.904.433 -88.5%
2016 1.543.000 -153.04%
2018 1.543 -99900%
2019 0 0%
2020 0 0%
2021 0 0%
2022 19.316 100%
2023 952.304 97.97%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Psykey, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2005 0
2006 0 0%
2007 0 0%
2008 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Psykey, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2005 0
2006 0 0%
2007 0 0%
2008 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Psykey, Inc. EBITDA
Year EBITDA Growth
2005 -25.771
2006 -10.752.189 99.76%
2007 -8.098.454 -32.77%
2008 -8.973.772 9.75%
2014 -996.090 -800.9%
2015 -1.390.510 28.37%
2016 -626.000 -122.13%
2018 -720 -86844.44%
2019 -4.330 83.37%
2020 0 0%
2021 -331.660 100%
2022 -355.790 6.78%
2023 -1.011.160 64.81%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Psykey, Inc. Gross Profit
Year Gross Profit Growth
2005 0
2006 0 0%
2007 0 0%
2008 0 0%
2014 897.959 100%
2015 -352.019 355.09%
2016 603.000 158.38%
2018 603 -99900%
2019 -6 10150%
2020 0 0%
2021 0 0%
2022 11.265 100%
2023 943.492 98.81%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Psykey, Inc. Net Profit
Year Net Profit Growth
2005 -25.771
2006 -11.117.316 99.77%
2007 -9.302.156 -19.51%
2008 -9.129.544 -1.89%
2014 -1.423.831 -541.2%
2015 -1.722.388 17.33%
2016 -602.000 -186.11%
2018 -696 -86394.25%
2019 -4.360 84.04%
2020 0 0%
2021 -343.699 100%
2022 -497.760 30.95%
2023 -3.055.104 83.71%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Psykey, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2005 0
2006 -1 100%
2007 -1 0%
2008 -1 0%
2014 0 0%
2015 0 0%
2016 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Psykey, Inc. Free Cashflow
Year Free Cashflow Growth
2005 -26.040
2006 -8.751.243 99.7%
2007 -6.949.819 -25.92%
2008 -311.636 -2130.11%
2014 -1.818.020 82.86%
2015 -1.775.094 -2.42%
2016 -733.000 -142.17%
2018 -602 -121660.8%
2019 -4.360 86.19%
2020 157 2877.07%
2021 -92.312 100.17%
2022 -92.891 0.62%
2023 95.322 197.45%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Psykey, Inc. Operating Cashflow
Year Operating Cashflow Growth
2005 -26.040
2006 -7.455.868 99.65%
2007 -6.880.338 -8.36%
2008 -311.636 -2107.81%
2014 -1.541.784 79.79%
2015 -1.765.256 12.66%
2016 -733.000 -140.83%
2018 -602 -121660.8%
2019 -4.360 86.19%
2020 157 2877.07%
2021 -92.312 100.17%
2022 -92.891 0.62%
2023 95.322 197.45%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Psykey, Inc. Capital Expenditure
Year Capital Expenditure Growth
2005 0
2006 1.295.375 100%
2007 69.481 -1764.36%
2008 0 0%
2014 276.236 100%
2015 9.838 -2707.85%
2016 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Psykey, Inc. Equity
Year Equity Growth
2005 -786
2006 5.986.892 100.01%
2007 852.050 -602.65%
2008 -210.441 504.89%
2014 -1.216.524 82.7%
2015 -2.938.912 58.61%
2016 -3.540.000 16.98%
2018 204.547 1830.65%
2019 204.547 0%
2020 -4.790 4370.29%
2021 -361.784 98.68%
2022 -812.277 55.46%
2023 -746.659 -8.79%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Psykey, Inc. Assets
Year Assets Growth
2005 4.344
2006 7.859.093 99.94%
2007 2.258.344 -248%
2008 197.183 -1045.3%
2014 1.353.385 85.43%
2015 1.175.080 -15.17%
2016 995.000 -18.1%
2018 209.337 -375.31%
2019 209.337 0%
2020 0 0%
2021 626.705 100%
2022 574.965 -9%
2023 1.727.360 66.71%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Psykey, Inc. Liabilities
Year Liabilities Growth
2005 5.130
2006 1.872.201 99.73%
2007 1.406.294 -33.13%
2008 407.624 -245%
2014 2.569.909 84.14%
2015 4.113.992 37.53%
2016 4.535.000 9.28%
2018 4.790 -94576.41%
2019 4.790 0%
2020 4.790 0%
2021 988.489 99.52%
2022 1.387.242 28.74%
2023 2.474.019 43.93%

Psykey, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0
Net Income per Share
-0
Price to Earning Ratio
-6.13x
Price To Sales Ratio
0.69x
POCF Ratio
42.87
PFCF Ratio
1.79
Price to Book Ratio
-9.91
EV to Sales
2.23
EV Over EBITDA
-1.35
EV to Operating CashFlow
5.33
EV to FreeCashFlow
5.74
Earnings Yield
-0.16
FreeCashFlow Yield
0.56
Market Cap
0,00 Bil.
Enterprise Value
0,00 Bil.
Graham Number
0.01
Graham NetNet
-0.01

Income Statement Metrics

Net Income per Share
-0
Income Quality
-0.14
ROE
6.72
Return On Assets
-0.7
Return On Capital Employed
5.65
Net Income per EBT
1
EBT Per Ebit
1.76
Ebit per Revenue
-1.66
Effective Tax Rate
0

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.99
Operating Profit Margin
-1.66
Pretax Profit Margin
-2.92
Net Profit Margin
-2.92

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
0
Free CashFlow per Share
0
Capex to Operating CashFlow
0.07
Capex to Revenue
0.03
Capex to Depreciation
5.58
Return on Invested Capital
-2.61
Return on Tangible Assets
-2.73
Days Sales Outstanding
0
Days Payables Outstanding
175802.53
Days of Inventory on Hand
8047.73
Receivables Turnover
0
Payables Turnover
0
Inventory Turnover
0.05
Capex per Share
0

Balance Sheet

Cash per Share
0,00
Book Value per Share
0,00
Tangible Book Value per Share
-0.01
Shareholders Equity per Share
-0
Interest Debt per Share
0
Debt to Equity
-1.35
Debt to Assets
0.59
Net Debt to EBITDA
-0.93
Current Ratio
0.24
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
-121659
Working Capital
0,00 Bil.
Intangibles to Total Assets
0.74
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
49400
Debt to Market Cap
3.52

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Psykey, Inc. Dividends
Year Dividends Growth

Psykey, Inc. Profile

About Psykey, Inc.

Psykey, Inc. engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines to improve and optimize life. The company also engages in the development of technologies for the composition, bioavailability, and targeted delivery of entheogen-based therapeutics for the psychedelic market. Its retail products include functional mushroom coffees and teas, oral supplements, and single serve drink mixes. The company was formerly known as CeCors, Inc. and changed its name to Psykey, Inc. in August 2021. Psykey, Inc. was founded in 2002 and is based in Toronto, Canada.

CEO
Ms. Kate Monroe
Employee
6
Address
17 Belfield Road
Toronto, M9W1E8

Psykey, Inc. Executives & BODs

Psykey, Inc. Executives & BODs
# Name Age
1 Mr. Amar Singh Bhatal
Co-Founder, President, Secretary & Director
70
2 Mr. John Gustin
Head of Global Business Development
70
3 Mr. Sukhinderpaul Kalsi
Co-Founder, Chief Financial Officer, Treasurer & Director
70
4 Mr. Mark Perkell
Vice President and General Counsel
70
5 Jacqueline Rae Danforth
Compliance Officer & Accountant
70
6 Ms. Kate Monroe
Chief Executive Officer
70

Psykey, Inc. Competitors